发布求助
文献互助 智能选刊 最新文献

Postepy biochemii最新文献

筛选
英文 中文
The role of the AP2 Adaptor Protein Complex in clathrin-mediated endocytosis AP2接头蛋白复合物在网格蛋白介导的内吞作用中的作用
Postepy biochemii Pub Date : 2026-10-06 DOI: 10.18388/471m2c74
Wiktoria Kowalska, Aleksandra Tempes
{"title":"The role of the AP2 Adaptor Protein Complex in clathrin-mediated endocytosis","authors":"Wiktoria Kowalska, Aleksandra Tempes","doi":"10.18388/471m2c74","DOIUrl":"https://doi.org/10.18388/471m2c74","url":null,"abstract":"<p><p>This work presents an overall characterization of the endocytosis process, including its various forms, stages, and biological significance. Particular emphasis is placed on clathrin-mediated endocytosis (CME) and the adaptor protein complexes AP1–AP5 that participate in this pathway. Their structure, subcellular localization, function, as well as the disorders and diseases associated with them are addressed. The main attention is devoted to the AP2 complex, which is indispensable in CME. The conformational changes of this complex and their importance in the initiation and progression of clathrin-mediated endocytosis are analysed in detail. The influence of phosphorylation of one of the AP2 subunits on these conformational changes and the positive and negative regulation of the entire AP2 complex by kinases and NECAP proteins is discussed. The study also emphasizes the importance of AP2 in the proper functioning of the nervous system, as well as the associations between structural disruptions of the complex and neurodegenerative diseases, highlighting the therapeutic potential arising from the regulation of its subunit expression.</p>","PeriodicalId":20335,"journal":{"name":"Postepy biochemii","volume":"72 3","pages":"227-242"},"PeriodicalIF":0.0,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149114108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Julius Marmur – „One word or less” Julius Marmur -“一个词或更少”
Postepy biochemii Pub Date : 2026-10-06 DOI: 10.18388/kdrfgh70
Agnieszka Gęgotek, Elżbieta Skrzydlewska
{"title":"Julius Marmur – „One word or less”","authors":"Agnieszka Gęgotek, Elżbieta Skrzydlewska","doi":"10.18388/kdrfgh70","DOIUrl":"https://doi.org/10.18388/kdrfgh70","url":null,"abstract":"<p><p>Julius Marmur (1926-1996) was born in Białystok, however, he spent most of his life in the USA, where he worked at leading research institutions, including Rockefeller University, Albert Einstein College of Medicine, and Harvard University. His discoveries regarding DNA functioning today are the fundamental biochemical knowledge. Thanks to his work, we understand the mechanism native DNA thermal denaturation with the loss of biological activity, and the method of reassembling a transforming DNA. Julius Marmur also demonstrated that a single DNA strand (even labeled) can be combined with a strand of another homologous molecule, thus forming a biologically active double helix. For these discoveries, he was nominated with Paul Doty for the Nobel Prize in Chemistry in 1972. Although 100 years after his birth, his scientific discoveries represented a major step towards the creation of recombinant DNA, transforming the way scientists understood DNA and how they could work with it in vitro.</p>","PeriodicalId":20335,"journal":{"name":"Postepy biochemii","volume":"72 3","pages":"243-246"},"PeriodicalIF":0.0,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149114052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potential role of CHI3L1 in ischemic stroke - a neuroinflammatory or neuroprotective factor? CHI3L1在缺血性卒中中的潜在作用——神经炎症因子还是神经保护因子？
Postepy biochemii Pub Date : 2026-10-06 DOI: 10.18388/wht2rw10
Aleksandra Klachacz, Anna Malik
{"title":"Potential role of CHI3L1 in ischemic stroke - a neuroinflammatory or neuroprotective factor?","authors":"Aleksandra Klachacz, Anna Malik","doi":"10.18388/wht2rw10","DOIUrl":"https://doi.org/10.18388/wht2rw10","url":null,"abstract":"<p><p>Ischemic stroke is one of the leading causes of disability and death among adults worldwide. It occurs when blood flow to the brain is interrupted. Currently available treatments for patients with ischemic stroke focus solely on restoring blood flow. Therefore, there is a lack of methods that would accelerate brain regeneration after a stroke or even provide a protective effect. This study describes the role of the astrocyte-secreted protein CHI3L1 (chitinase-3-like protein 1) in the pathophysiology of stroke, as well as other diseases of the central nervous system. The structure of the protein, the receptors to which CHI3L1 binds and the activated signaling pathways along with the resulting biological effects relevant to ischemic stroke are discussed. It is indicated that changes in CHI3L1 levels potentially influence post-stroke regeneration in both humans and animal models. The common mechanisms of CHI3L1 action across various neurological diseases suggest its significant role in the future diagnosis and treatment of ischemic stroke, Alzheimer’s and Parkinson’s diseases, and glioma.</p>","PeriodicalId":20335,"journal":{"name":"Postepy biochemii","volume":"72 3","pages":"201-210"},"PeriodicalIF":0.0,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149114016","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The mitochondrial Na⁺/Ca²⁺ exchanger NCLX in calcium homeostasis and disease pathophysiology: mechanisms, controversies and research perspectives 线粒体Na + / ca2 +交换剂NCLX在钙稳态和疾病病理生理中的作用：机制、争议和研究视角
Postepy biochemii Pub Date : 2026-10-06 DOI: 10.18388/kyvc2c25
Katarzyna Romaniuk
{"title":"The mitochondrial Na⁺/Ca²⁺ exchanger NCLX in calcium homeostasis and disease pathophysiology: mechanisms, controversies and research perspectives","authors":"Katarzyna Romaniuk","doi":"10.18388/kyvc2c25","DOIUrl":"https://doi.org/10.18388/kyvc2c25","url":null,"abstract":"<p><p>Mitochondrial calcium homeostasis is an important regulator of bioenergetics, redox balance and cell survival. This review discusses the structure, regulation and pathophysiological significance of the mitochondrial Na⁺/Ca²⁺ exchanger NCLX, encoded by the SLC8B1 gene. Particular attention is paid to the role of NCLX in Ca²⁺ efflux from the mitochondrial matrix, integration of Na⁺–Ca²⁺–ROS signaling, and cellular responses to metabolic stress, hypoxia and mitochondrial injury. The available data indicate that NCLX dysfunction contributes to the pathophysiology of neurodegenerative, cardiovascular, metabolic, inflammatory and neoplastic diseases. However, the function of this transporter strongly depends on cell type, duration of stress and the degree of mitochondrial Ca²⁺ overload. Therefore, NCLX should be considered a regulator of mitochondrial function whose diagnostic, prognostic and therapeutic relevance requires further validation in experimental and clinical studies.</p>","PeriodicalId":20335,"journal":{"name":"Postepy biochemii","volume":"72 3","pages":"187-200"},"PeriodicalIF":0.0,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149114091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Zinc homeostasis in plants: the role of ZIP, MTP and HMA transporters and chelating agents 锌在植物体内的动态平衡：ZIP、MTP和HMA转运体和螯合剂的作用
Postepy biochemii Pub Date : 2026-10-06 DOI: 10.18388/1sjq4a75
Ewa Borzęcka, Anna Barabasz
{"title":"Zinc homeostasis in plants: the role of ZIP, MTP and HMA transporters and chelating agents","authors":"Ewa Borzęcka, Anna Barabasz","doi":"10.18388/1sjq4a75","DOIUrl":"https://doi.org/10.18388/1sjq4a75","url":null,"abstract":"<p><p>Zinc (Zn) is an essential micronutrient involved in numerous physiological processes in plants, serving catalytic, structural, and regulatory functions. Maintaining its appropriate concentration requires precise control of uptake, transport, distribution, and storage, as both Zn deficiency and excess lead to disruptions in plant growth and development. This paper presents the mechanisms regulating zinc homeostasis in plants, with a particular focus on the role of membrane transporters and chelating compounds. The ZIP, MTP, and HMA protein families play a key role, being responsible for cellular Zn uptake, its sequestration within organelles, and inter-tissue transport, respectively. Low-molecular-weight chelating ligands maintain safe zinc levels in the cytosol, and some of them facilitate its storage in vacuoles. Furthermore, they enhance its symplastic mobility and enable zinc transport in the xylem and phloem, thereby facilitating its distribution to shoots and seeds. Overall, this demonstrates the complex and multilevel nature of zinc homeostasis regulation in plants</p>","PeriodicalId":20335,"journal":{"name":"Postepy biochemii","volume":"72 3","pages":"211-226"},"PeriodicalIF":0.0,"publicationDate":"2026-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149114070","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
REST in central nervous system tumors REST在中枢神经系统肿瘤中的作用
Postepy biochemii Pub Date : 2026-07-03 DOI: 10.18388/t9qmjg04
Zuzanna Bieńkowska, Maciej Ołdak, Marta Maleszewska
{"title":"REST in central nervous system tumors","authors":"Zuzanna Bieńkowska, Maciej Ołdak, Marta Maleszewska","doi":"10.18388/t9qmjg04","DOIUrl":"https://doi.org/10.18388/t9qmjg04","url":null,"abstract":"<p><p>The transcription factor REST (RE1-silencing transcription factor) is a key regulator of neuronal gene expression, playing a role in normal brain development and in the pathogenesis of central nervous system (CNS) tumors. By binding RE1 sequences and recruiting repressive complexes, it participates in epigenetic gene silencing, controlling the processes of neurogenesis and cellular differentiation. In CNS tumors, REST exhibits context-dependent effects, most often acting as an oncogene.\u0000\u0000Deregulation of its expression promotes pro-tumor processes, such as maintaining tumor stem cell properties, inhibiting differentiation, proliferation and increased invasiveness, angiogenesis, adaptation to hypoxia, and shaping the tumor microenvironment. Accumulating evidence indicates its potential as a biomarker and therapeutic target, making REST a promising element of treatment strategies for CNS tumors.</p>","PeriodicalId":20335,"journal":{"name":"Postepy biochemii","volume":"72 2","pages":"155-172"},"PeriodicalIF":0.0,"publicationDate":"2026-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148387746","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Plant Iridoid Glycosides: Biological Properties and Pharmacological Potential 植物环烯醚萜苷：生物学特性和药理潜力
Postepy biochemii Pub Date : 2026-06-30 DOI: 10.18388/wbg5q048
Ewa Młodzińska-Michta, Natalia Gaik
{"title":"Plant Iridoid Glycosides: Biological Properties and Pharmacological Potential","authors":"Ewa Młodzińska-Michta, Natalia Gaik","doi":"10.18388/wbg5q048","DOIUrl":"https://doi.org/10.18388/wbg5q048","url":null,"abstract":"<p><p>Iridoid glycosides are a diverse group of plant secondary metabolites with broad biological activity and promising pharmacological potential. This review summarizes their structural diversity, occurrence in plants, biosynthetic pathways, and biological properties. Particular attention is given to the biosynthesis derived from IPP and DMAPP, including the well-characterized secoiridoid pathway and the less understood pathway leading to compounds such as aucubin and catalpol. The most important biological activities of iridoids, including antibacterial, anti-inflammatory, neuroprotective, gastroprotective, and anticancer effects, are discussed with clear distinction between in vitro studies, animal models, and limited clinical evidence. The review emphasizes that most available data remain preclinical, while clinical studies are still scarce. Major limitations affecting the therapeutic application of iridoids include low bioavailability, variable chemical stability, lack of extract standardization, and difficulties in translating experimental findings into clinical practice.</p>","PeriodicalId":20335,"journal":{"name":"Postepy biochemii","volume":"72 2","pages":"143-154"},"PeriodicalIF":0.0,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148387677","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The role of miRNAs in the pathogenesis, diagnosis, and personalized therapy of glioblastoma multiforme mirna在多形性胶质母细胞瘤发病机制、诊断和个性化治疗中的作用
Postepy biochemii Pub Date : 2026-06-30 DOI: 10.18388/cjm9bt80
Anna Bielecka-Wajdman
{"title":"The role of miRNAs in the pathogenesis, diagnosis, and personalized therapy of glioblastoma multiforme","authors":"Anna Bielecka-Wajdman","doi":"10.18388/cjm9bt80","DOIUrl":"https://doi.org/10.18388/cjm9bt80","url":null,"abstract":"<p><p>Glioblastoma multiforme (GBM) is a malignant, hypercellular, and invasive brain tumor characterized by high mortality and recurrence. Their strong heterogeneity, mitotic activity, microvascular proliferation, and foci of necrosis induce therapeutic resistance, resulting in a 5-year survival rate of only 5% in patients diagnosed with glioblastoma. Therefore, it is necessary to identify new targets to improve prognosis, better predict prognosis, and monitor treatment outcomes. It has been suggested that miRNAs—small, single-stranded, non-coding RNAs consisting of 20-22 nucleotides—may be potential candidates for clinical biomarkers in glioblastoma patients. They participate in the post-translational regulation of gene expression through RNA interference. It is believed that, due to their ability to control the biological processes underlying GBM development, miRNAs may aid in the design of drugs for personalized glioma therapy. This article presents the latest insights into the role of miRNAs in the pathogenesis and diagnosis of GBM and as a potential therapeutic target.</p>","PeriodicalId":20335,"journal":{"name":"Postepy biochemii","volume":"72 2","pages":"125-142"},"PeriodicalIF":0.0,"publicationDate":"2026-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148387722","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of analytical protein microarrays in the diagnosis and therapy of lung cancer 分析蛋白微阵列技术在肺癌诊断和治疗中的应用
Postepy biochemii Pub Date : 2026-06-23 DOI: 10.18388/ptr62z92
Wiktoria Pławecka
{"title":"Application of analytical protein microarrays in the diagnosis and therapy of lung cancer","authors":"Wiktoria Pławecka","doi":"10.18388/ptr62z92","DOIUrl":"https://doi.org/10.18388/ptr62z92","url":null,"abstract":"<p><p>Lung cancer is one of the most commonly diagnosed cancers and a leading cause of cancer-related deaths. Analytical protein microarrays are a promising diagnostic tool, particularly for early disease detection. They enable rapid and sensitive analysis of multiple biomarkers, outperforming traditional methods, and allow for differentiation of lung cancer types, supporting personalized medicine. An additional advantage is the ability to analyze non-invasive samples, such as serum. Despite certain limitations, this technology is developing dynamically. The aim of this thesis is to present the principles of operation, structure, and analytical applications of protein microarrays as advanced diagnostic tools in molecular biology and in the study of protein interactions. The thesis also discusses the benefits resulting from the use of this technology, its advantages over traditional methods, as well as the limitations affecting its practical application in diagnostics and cancer therapy.</p>","PeriodicalId":20335,"journal":{"name":"Postepy biochemii","volume":"72 2","pages":"113-124"},"PeriodicalIF":0.0,"publicationDate":"2026-06-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148387884","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of phytotherapeutics in diagnosis and treatment of diabetes 植物疗法在糖尿病诊断和治疗中的作用
Postepy biochemii Pub Date : 2026-06-13 DOI: 10.18388/gnvzwf18
Anastazja Woźniczka, Wiktor Pełka, Aleksandra Tarasiuk-Zawadzka, Jakub Fichna
{"title":"Role of phytotherapeutics in diagnosis and treatment of diabetes","authors":"Anastazja Woźniczka, Wiktor Pełka, Aleksandra Tarasiuk-Zawadzka, Jakub Fichna","doi":"10.18388/gnvzwf18","DOIUrl":"https://doi.org/10.18388/gnvzwf18","url":null,"abstract":"<p><p>Phytotherapy relies on biologically active plant-derived compounds and preparations. The use of phytotherapeutics in treatment of diabetes consequently increases. Many plant extracts interact with key elements of glucose metabolism, e.g. through modulation of DPP-4 activity, increase in glucose intake by tissues and improvement of pancreatic beta-cells. Experimental data indicates that Hairy Rock-rose, tea plant, European olive, American ginseng, berberis or white mulberry can support glycemic control and limit the development of metabolic side effects. Despite vast literature data, the clinical efficacy of several phytotherapeutics remains ambiguous, what indicates the need to conduct further research, in particular well-designed clinical studies. Here we review plants with therapeutic potential, whose use in the treatment of diabetes has been confirmed by experimental in vitro, in vivo and clinical studies; promising directions in future studies on phytotherapeutics have also been indicated.</p>","PeriodicalId":20335,"journal":{"name":"Postepy biochemii","volume":"72 2","pages":"99-112"},"PeriodicalIF":0.0,"publicationDate":"2026-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148387773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书